147 related articles for article (PubMed ID: 16900441)
1. Cardioprotection mediated by rosiglitazone, a peroxisome proliferator-activated receptor gamma ligand, in relation to nitric oxide.
Gonon AT; Bulhak A; Labruto F; Sjöquist PO; Pernow J
Basic Res Cardiol; 2007 Jan; 102(1):80-9. PubMed ID: 16900441
[TBL] [Abstract][Full Text] [Related]
2. Contribution of NO to ischemia-reperfusion injury in the saline-perfused heart: a study in endothelial NO synthase knockout mice.
Flögel U; Decking UK; Gödecke A; Schrader J
J Mol Cell Cardiol; 1999 Apr; 31(4):827-36. PubMed ID: 10329210
[TBL] [Abstract][Full Text] [Related]
3. Protection against myocardial ischaemia/reperfusion injury by PPAR-alpha activation is related to production of nitric oxide and endothelin-1.
Bulhak AA; Sjöquist PO; Xu CB; Edvinsson L; Pernow J
Basic Res Cardiol; 2006 May; 101(3):244-52. PubMed ID: 16411023
[TBL] [Abstract][Full Text] [Related]
4. Effect of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on ischemia-reperfusion injury in rats.
Cao Z; Ye P; Long C; Chen K; Li X; Wang H
Pharmacology; 2007; 79(3):184-92. PubMed ID: 17356310
[TBL] [Abstract][Full Text] [Related]
5. Telmisartan inhibits vasoconstriction via PPARγ-dependent expression and activation of endothelial nitric oxide synthase.
Yuen CY; Wong WT; Tian XY; Wong SL; Lau CW; Yu J; Tomlinson B; Yao X; Huang Y
Cardiovasc Res; 2011 Apr; 90(1):122-9. PubMed ID: 21156825
[TBL] [Abstract][Full Text] [Related]
6. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor-gamma, prevents contralateral testicular ischaemia-reperfusion injury in prepubertal rats.
Inan M; Basaran U; Dokmeci D; Kanter M; Yalcin O; Aydogdu N; Turan N
Clin Exp Pharmacol Physiol; 2007; 34(5-6):457-61. PubMed ID: 17439415
[TBL] [Abstract][Full Text] [Related]
7. Pioglitazone ameliorates endothelial dysfunction and restores ischemia-induced angiogenesis in diabetic mice.
Huang PH; Sata M; Nishimatsu H; Sumi M; Hirata Y; Nagai R
Biomed Pharmacother; 2008 Jan; 62(1):46-52. PubMed ID: 17692499
[TBL] [Abstract][Full Text] [Related]
8. Deletion of endothelial nitric oxide synthase exacerbates myocardial stunning in an isolated mouse heart model.
Hannan RL; John MC; Kouretas PC; Hack BD; Matherne GP; Laubach VE
J Surg Res; 2000 Sep; 93(1):127-32. PubMed ID: 10945953
[TBL] [Abstract][Full Text] [Related]
9. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
Lin MS; Chen WC; Bai X; Wang YD
J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
Luo Y; Yin W; Signore AP; Zhang F; Hong Z; Wang S; Graham SH; Chen J
J Neurochem; 2006 Apr; 97(2):435-48. PubMed ID: 16539667
[TBL] [Abstract][Full Text] [Related]
11. The PPARgamma ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice.
Hwang J; Kleinhenz DJ; Rupnow HL; Campbell AG; Thulé PM; Sutliff RL; Hart CM
Vascul Pharmacol; 2007 Jun; 46(6):456-62. PubMed ID: 17337254
[TBL] [Abstract][Full Text] [Related]
12. Rosiglitazone-induced myocardial protection against ischaemia-reperfusion injury is mediated via a phosphatidylinositol 3-kinase/Akt-dependent pathway.
Zhang XJ; Xiong ZB; Tang AL; Ma H; Ma YD; Wu JG; Dong YG
Clin Exp Pharmacol Physiol; 2010 Feb; 37(2):156-61. PubMed ID: 19566839
[TBL] [Abstract][Full Text] [Related]
13. Rosiglitazone increases PPARgamma in renal tubular epithelial cells and protects against damage by hydrogen peroxide.
Sommer M; Wolf G
Am J Nephrol; 2007; 27(4):425-34. PubMed ID: 17622750
[TBL] [Abstract][Full Text] [Related]
14. The macrophage-mediated effects of the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone attenuate tactile allodynia in the early phase of neuropathic pain development.
Takahashi Y; Hasegawa-Moriyama M; Sakurai T; Inada E
Anesth Analg; 2011 Aug; 113(2):398-404. PubMed ID: 21490083
[TBL] [Abstract][Full Text] [Related]
15. [Effect of 17beta-estradiol on myocardial inducible NOS and endothelial NOS activities after ischemia-reperfusion in rat heart model].
Wang XD; Wang ZM; Jia DL; Yu P
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1789-91. PubMed ID: 17919391
[TBL] [Abstract][Full Text] [Related]
16. 15-deoxy-Delta12,14 prostaglandin GJ2 but not rosiglitazone regulates metalloproteinase 9, NOS-2, and cyclooxygenase 2 expression and functions by peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms in cardiac cells.
Hovsepian E; Penas F; Goren NB
Shock; 2010 Jul; 34(1):60-7. PubMed ID: 19997048
[TBL] [Abstract][Full Text] [Related]
17. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces the development of nonseptic shock induced by zymosan in mice.
Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Fulia F; Cuzzocrea E; Di Rosa M; Caputi AP; Thiemermann C
Crit Care Med; 2004 Feb; 32(2):457-66. PubMed ID: 14758164
[TBL] [Abstract][Full Text] [Related]
18. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
[TBL] [Abstract][Full Text] [Related]
19. Infarct size and nitric oxide synthase in murine myocardium.
Sumeray MS; Rees DD; Yellon DM
J Mol Cell Cardiol; 2000 Jan; 32(1):35-42. PubMed ID: 10652188
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor gamma-independent effects of thiazolidinediones on human cardiac myofibroblast function.
Mughal RS; Warburton P; O'Regan DJ; Ball SG; Turner NA; Porter KE
Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):478-86. PubMed ID: 19673929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
